GFRA1 and congenital rubella syndrome: Bonferroni post-test analysis revealed that the levels of spermatogenic cell marker was significantly reduced in the CRS + NS group compared with Control + NS group (AR:t = 1.984, P = 0.1780; CD29:t = 4.493, P = 0.0005; GFRA1:t = 5.440, P = 0.0002), which was recovered by BET treatment (AR:t = 1.157, P = 0.7773; CD29:t = 3.095, P = 0.0153; GFRA1:t = 1.361, P = 0.5811).